Favipiravir
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 (NCT04376814) | Baqiyatallah Medical Sciences University | 2020-03-29 |
Track Favipiravir automatically
Every clearance here is in the API, with alerts when new ones post.